QT
MCRB icon

Quantamental Technologies’s Seres Therapeutics MCRB Stock Holding History

Quantamental Technologies’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,074
Closed -$179K – 490
2021
Q4 		$179K Buy
1,074
+207
+24% +$32.9K 0.09% 342
2021
Q3 		$121K Buy
+867
New +$170K 0.08% 272
2019
Q4 		– Sell
-79
Closed -$6K – 948
2019
Q3 		$6K Sell
79
-15
-16% -$991 ﹤0.01% 1369
2019
Q2 		$6K Buy
+94
New +$8.92K ﹤0.01% 1310

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Quantamental Technologies's MCRB Position: Q1 2022 in Review

Quantamental Technologies sold out of Seres Therapeutics (MCRB) in Q1 2022, closing a stake of 1,074 shares — an estimated $179K sold.

Quantamental Technologies first reported a position in MCRB in Q2 2019 and held it in 4 quarters. The position peaked at $179K in Q4 2021. 131 funds tracked by Wall St. Rank hold MCRB as of Q1 2022.

  • Quantamental Technologies reported no remaining Seres Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Quantamental Technologies sold 1,074 Seres Therapeutics shares in Q1 2022, an estimated $179K.
  • Quantamental Technologies first reported a position in Seres Therapeutics in Q2 2019 and held it in 4 quarters.
  • Quantamental Technologies's Seres Therapeutics position peaked at $179K in Q4 2021.
  • 131 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2022.

Based on Quantamental Technologies's 13F filing for Q1 2022, filed 16 May 2022.